PE20050369A1 - Derivados de bencimidazol sustituidos con haloalquilo y piperidina - Google Patents

Derivados de bencimidazol sustituidos con haloalquilo y piperidina

Info

Publication number
PE20050369A1
PE20050369A1 PE2004000811A PE2004000811A PE20050369A1 PE 20050369 A1 PE20050369 A1 PE 20050369A1 PE 2004000811 A PE2004000811 A PE 2004000811A PE 2004000811 A PE2004000811 A PE 2004000811A PE 20050369 A1 PE20050369 A1 PE 20050369A1
Authority
PE
Peru
Prior art keywords
haloalkyl
piperidine
fluoro
benzimidazole derivatives
het
Prior art date
Application number
PE2004000811A
Other languages
English (en)
Inventor
Ralf Anderskewitz
Franz Birke
Pascale Pouzet
Horst Dollinger
Dominic Martyres
Thierry Bouyssou
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of PE20050369A1 publication Critical patent/PE20050369A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B35/00—Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
    • C04B35/622—Forming processes; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
    • C04B35/626—Preparing or treating the powders individually or as batches ; preparing or treating macroscopic reinforcing agents for ceramic products, e.g. fibres; mechanical aspects section B
    • C04B35/63—Preparing or treating the powders individually or as batches ; preparing or treating macroscopic reinforcing agents for ceramic products, e.g. fibres; mechanical aspects section B using additives specially adapted for forming the products, e.g.. binder binders
    • C04B35/632—Organic additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Ceramic Engineering (AREA)
  • Manufacturing & Machinery (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Materials Engineering (AREA)
  • Structural Engineering (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

REFERIDA A UN COMPUESTO DE FORMULA 1 DONDE R1 ES ARILO, HET, ENTRE OTROS; R5 ES HALOALQUILO C1-C6; R6 ES ALQUILO C1-C6, ALCOXI C1-C6, ACILOXI C1-C6, ENTRE OTROS; A ES ALQUILENO C2-C8, OPCIONALMENTE SUSTITUIDO CON ALQUILO C1-C3, HALOGENO U OH; B ES ARILO O HET; Y ES ENLACE -CH2, -CF2, -O-, ENTRE OTROS; i Y j SON CADA UNO 1-3; m ES 0-4. TAMBIEN REFERIDA A UNA COMPOSICION FARMACEUTICA CUYOS COMPUESTOS PREFERIDOS SON: 1-BENCIL-4-(4-FLUORO-2-NITRO-FENILAMINO)-PIPERIDINA; 1-(1-BENCIL-PIPERIDIN-4-IL)-5-FLUORO-2-PENTAFLUOROETIL-1H-BENCIMIDAZOL Y 1-(3-BROMO-PROPILSULFANIL)-4-FLUORO-BENCENO; ENTRE OTROS. DICHOS COMPUESTOS SON MODULADORES DE LA ACTIVIDAD DEL RECEPTOR DE QUIMOQUINA UTILES EN CASOS DE ASMA, ENFERMEDADES ALERGICAS Y ATEROSCLEROSIS, ENTRE OTRAS
PE2004000811A 2003-08-25 2004-08-23 Derivados de bencimidazol sustituidos con haloalquilo y piperidina PE20050369A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03018705 2003-08-25

Publications (1)

Publication Number Publication Date
PE20050369A1 true PE20050369A1 (es) 2005-06-24

Family

ID=34203215

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2004000811A PE20050369A1 (es) 2003-08-25 2004-08-23 Derivados de bencimidazol sustituidos con haloalquilo y piperidina

Country Status (11)

Country Link
EP (1) EP1660476B1 (es)
JP (1) JP4783286B2 (es)
AR (1) AR045491A1 (es)
AT (1) ATE349441T1 (es)
CA (1) CA2536787C (es)
DE (1) DE602004003965T2 (es)
ES (1) ES2279423T3 (es)
PE (1) PE20050369A1 (es)
TW (1) TW200514778A (es)
UY (1) UY28490A1 (es)
WO (1) WO2005019203A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006117314A2 (en) * 2005-04-30 2006-11-09 Boehringer Ingelheim International Gmbh Novel piperidin- substituted indoles and their use as ccr-3 modulators
AU2006314264B2 (en) * 2005-11-15 2012-07-19 Latchways Plc. Safety device

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5567711A (en) * 1995-04-19 1996-10-22 Abbott Laboratories Indole-3-carbonyl and indole-3-sulfonyl derivatives as platelet activating factor antagonists
GB0005642D0 (en) * 2000-03-10 2000-05-03 Astrazeneca Uk Ltd Chemical compounds

Also Published As

Publication number Publication date
EP1660476B1 (en) 2006-12-27
JP2007503411A (ja) 2007-02-22
CA2536787A1 (en) 2005-03-03
ES2279423T3 (es) 2007-08-16
UY28490A1 (es) 2005-03-31
DE602004003965T2 (de) 2007-04-26
EP1660476A1 (en) 2006-05-31
DE602004003965D1 (de) 2007-02-08
TW200514778A (en) 2005-05-01
JP4783286B2 (ja) 2011-09-28
AR045491A1 (es) 2005-11-02
WO2005019203A1 (en) 2005-03-03
CA2536787C (en) 2012-02-21
ATE349441T1 (de) 2007-01-15

Similar Documents

Publication Publication Date Title
PE20040687A1 (es) Quinolinas sustituidas como antagonistas del receptor ccr5
PE20060598A1 (es) Derivado heterociclo conteniendo nitrogeno como antagonista de quimiocina ccr5
PE20070490A1 (es) Compuestos derivados de bencimidazol-2-ona sustituidos con piperidina como agonistas del receptor muscarinico m1
PE20060854A1 (es) Derivados de piperidina como antagonistas del receptor cc quimioquina ccr1
PE20081238A1 (es) Piperidinas sustituidas como antagonistas de hdm2
PE20081845A1 (es) Nuevos derivados de aminopirimidina como inhibidores de plk1
PE20000166A1 (es) Compuestos 4-(2-ceto-1-benzilimidazolinil)piperidina como agonistas del receptor orl1
PE20090482A1 (es) Derivados heterociclicos como antagonistas del receptor ccr2
PE20040680A1 (es) Inhibidores novedosos de cinasas
PE20051169A1 (es) Derivados de 2-(piperidina-amino-carbonil)-benzofusionados como antagonistas del receptor de quimiocina
PE20070808A1 (es) COMPUESTOS DERIVADOS DE ISOQUINOLINA COMO INHIBIDORES DE Rho-QUINASA
FI970771A (fi) Uusia allergisten sairauksien hoidossa käyttökelpoisia substituoituja piperidiinejä
PE20110328A1 (es) Compuestos heterociclicos fusionados como moduladores del receptor de la orexina
NZ594765A (en) Anthelmintic agents and their use
PE20060651A1 (es) Compuestos de aminoheteroarilo sustituidos con pirazol como inhibidores de proteina quinasa
PE20071232A1 (es) Derivados de piperidina o piperazina como inhibidores de 11-beta hsd1
PE20060736A1 (es) DERIVADOS DE PIRROL COMO ANTAGONISTAS DE CRTh2
PE20090237A1 (es) Derivados de sulfonamidas como inhibidores de los canales de sodio
PE20090982A1 (es) Derivados de piperidina como inhibidores de la proteina de transferencia de colesteril-ester (cetp)
PE20060373A1 (es) Derivados 3-piperidinil-7-carboxamida-indazol como inhibidores de la actividad cinasa de ikk2
PE20040290A1 (es) Derivados de piperidinas- benzodiazepinas como antagonistas del cgrp
PE20090621A1 (es) Pirrolidina-aril-eteres como antagonistas de receptores de nk3
PE20060298A1 (es) Derivados de acido carboxilico de bencimidazolona
PE20090622A1 (es) Nuevos derivados de bencimidazol sustituido
PE20110410A1 (es) Derivado de 7-piperidinoalquil-3,4-dihidroquinolona

Legal Events

Date Code Title Description
FA Abandonment or withdrawal